trending Market Intelligence /marketintelligence/en/news-insights/trending/ybS2I_GeFE7xSOyeyqK2sA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

EASY BIO Q3 loss narrows YOY


Minimizing Risk at a Bank with a Trade Intelligence Platform


2021 US broadband forecast lifted by rising digital home profiles


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Latin American and Caribbean Market Considerations Blog Series: Focus on IFRS 9

EASY BIO Q3 loss narrows YOY

EASY BIO Inc. said its third-quarter normalized net income came to a loss of 4.85 South Korean won per share, compared with a loss of 13.99 won per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of 245.1 million won, compared with a loss of 1.28 billion won in the prior-year period.

The normalized profit margin climbed to negative 0.1% from negative 0.4% in the year-earlier period.

Total revenue declined year over year to 348.07 billion won from 358.43 billion won, and total operating expenses fell on an annual basis to 343.25 billion won from 357.08 billion won.

Reported net income totaled 2.18 billion won, or 43.20 won per share, compared to a loss of 913.1 million won, or a loss of 19.00 won per share, in the year-earlier period.

As of Nov. 16, US$1 was equivalent to 1,172.80 South Korean won.